87 related articles for article (PubMed ID: 1965281)
21. Inhibition of macromolecular biosynthesis in cultured L1210 mouse leukemia cells by thalicarpine (NSC 68075).
Allen LM; Creaven PJ
Cancer Res; 1973 Dec; 33(12):3112-6. PubMed ID: 4796799
[No Abstract] [Full Text] [Related]
22. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
Geoffroy FJ; Allegra CJ; Sinha B; Grem JL
Oncol Res; 1994; 6(12):581-91. PubMed ID: 7787251
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of biosynthetic processes in P388 and Ehrlich ascites cells by cloturin.
Miko M; Krepelka J; Melka M
Drugs Exp Clin Res; 1988; 14(9):575-80. PubMed ID: 3229320
[TBL] [Abstract][Full Text] [Related]
24. Identification of a novel inhibitor (NSC 665564) of dihydroorotate dehydrogenase with a potency equivalent to brequinar.
Cleaveland ES; Zaharevitz DW; Kelley JA; Paull K; Cooney DA; Ford H
Biochem Biophys Res Commun; 1996 Jun; 223(3):654-9. PubMed ID: 8687451
[TBL] [Abstract][Full Text] [Related]
25. Dual effects of pyrazofurin and 3-deazauridine upon pyrimidine and purine biosynthesis in mouse L1210 leukemia.
Sant ME; Lyons SD; Kemp AJ; McClure LK; Szabados E; Christopherson RI
Cancer Res; 1989 May; 49(10):2645-50. PubMed ID: 2713848
[TBL] [Abstract][Full Text] [Related]
26. Antitumor activity of cytidine dialdehyde and its effects on nucleotide and nucleic acid synthesis.
Kinahan JJ; Pavelic ZP; Leonard RJ; Bloch A; Grindey GB
Cancer Res; 1980 Mar; 40(3):598-603. PubMed ID: 7471080
[TBL] [Abstract][Full Text] [Related]
27. The "anti-pyrimidine effect" of hypoxia and brequinar sodium (NSC 368390) is of consequence for tumor cell growth.
Löffler M
Biochem Pharmacol; 1992 May; 43(10):2281-7. PubMed ID: 1599514
[TBL] [Abstract][Full Text] [Related]
28. Antitumor activity of novel octalactin A analogs in murine leukemia cells in vitro.
Perchellet JP; Perchellet EM; Newell SW; Freeman JA; Ladesich JB; Jeong Y; Sato N; Buszek K
Anticancer Res; 1998; 18(1A):97-106. PubMed ID: 9568062
[TBL] [Abstract][Full Text] [Related]
29. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
Li ZR; Campbell J; Rustum YM
Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
[TBL] [Abstract][Full Text] [Related]
30. Effects of benzohydroxamic acids on L1210 lymphoid leukemia cell nucleic acid metabolism.
Hall IH; Taylor K; Izydore RA; Daniels DL
Pharmazie; 1998 Nov; 53(11):794-9. PubMed ID: 9853360
[No Abstract] [Full Text] [Related]
31. Characterization of L1210 cell growth inhibition by the bacterial iron chelators parabactin and compound II.
Cavanaugh PF; Porter CW; Tukalo D; Frankfurt OS; Pavelic ZP; Bergeron RJ
Cancer Res; 1985 Oct; 45(10):4754-9. PubMed ID: 4027962
[TBL] [Abstract][Full Text] [Related]
32. Dinaline inhibits amino acid transport and proliferation of colon carcinoma cells in vitro.
Schaider H; Haberkorn U; Stöhr M; Berger MR
Anticancer Res; 1995; 15(6B):2501-9. PubMed ID: 8669814
[TBL] [Abstract][Full Text] [Related]
33. Effects of N-hydroxy-N'-aminoguanidine derivatives on ribonucleotide reductase activity, nucleic acid synthesis, clonogenicity, and cell cycle of L1210 cells.
Weckbecker G; Weckbecker A; Lien EJ; Cory JG
Cancer Res; 1987 Feb; 47(4):975-8. PubMed ID: 2433036
[TBL] [Abstract][Full Text] [Related]
34. The relationship between dihydroorotic acid dehydrogenase and in vitro and in vivo cytostatic effects of brequinar sodium (DUP-785; NSC 368390).
Peters GJ; Laurensse E; de Kant E; Nadal JC; Pinedo HM
Adv Exp Med Biol; 1989; 253B():375-82. PubMed ID: 2558540
[No Abstract] [Full Text] [Related]
35. Effects of ethanolamine and choline on thiotepa cellular accumulation and cytotoxicity in L1210 cells.
Egorin MJ; Snyder SW; Wietharn BE
Cancer Res; 1990 Jul; 50(14):4322-7. PubMed ID: 2114213
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of synthesis of pyrimidine nucleotides by 2-hydroxy-3-(3,3-dichloroallyl)-1,4-naphthoquinone.
Bennett LL; Smithers D; Rose LM; Adamson DJ; Thomas HJ
Cancer Res; 1979 Dec; 39(12):4868-74. PubMed ID: 227592
[No Abstract] [Full Text] [Related]
37. 5-Hexyl-2'-deoxyuridine blocks the cytotoxic effects of 5-fluorodeoxyuridine or deoxyadenosine in leukemia L1210 cells in culture.
Cory JG; Halley MC; Jeney A; Lapis K
Cancer Res; 1990 Aug; 50(15):4552-6. PubMed ID: 2142444
[TBL] [Abstract][Full Text] [Related]
38. Antileukemic activity of synthetic daunomycinone derivatives bearing modifications in the glycosidic moiety.
Perchellet EM; Sperfslage BJ; McIlvain CJ; Aligiannis N; Pouli N; Marakos P; Skaltsounis AL; Perchellet JP
Anticancer Res; 2001; 21(6A):3957-67. PubMed ID: 11911277
[TBL] [Abstract][Full Text] [Related]
39. Regulation of pyrimidine biosynthesis in cultured L1210 cells by 3-deazauridine.
Karle JM; Cysyk RL
Biochem Pharmacol; 1984 Dec; 33(23):3739-42. PubMed ID: 6095859
[TBL] [Abstract][Full Text] [Related]
40. Antitumor activity and nucleic acid binding properties of dercitin, a new acridine alkaloid isolated from a marine Dercitus species sponge.
Burres NS; Sazesh S; Gunawardana GP; Clement JJ
Cancer Res; 1989 Oct; 49(19):5267-74. PubMed ID: 2548717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]